Minimal renal toxicity after Rituximab DHAP with a modified cisplatin application scheme in patients with relapsed or refractory diffuse large B-cell lymphoma - Kriegsmann, Katharina; Schöning, Tilman; Schwarzbich, Mark-Alexander; Cremer, Martin; Dittrich, Tobias; Ho, Anthony Dick; Witzens-Harig, Mathias (BMC cancer, 2016)
Gesehen am 08.11.2019